Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 95

Sort by

Sort Order Select

Journal Articles

Evaluation of Outcomes and Quality of Care in Children with Sickle Cell Disease Diagnosed By Newborn Screening: A Real-World Nation-Wide Study in France

Valentine Brousse, MD PhD, Cécile Arnaud, MD, Emmanuelle Lesprit, MD, Marie-Helene Odièvre-Montanié, MD PhD, Maryse Etienne-Julan, MD, Gisele Elana, MD, Marie Belloy, MD, Cecile Dumesnil, MD, Beatrice Quinet, MD, Abdourahim Chamouine, MD, Cecile Guillaumat, MD, Nathalie Garnier, MD, Corinne Pondarré, MD PhD, Nathalie Couque, PharmD, Francoise Bernaudin, MD, Mariane de Montalembert, MD PhD, Emmanuelle Boutin, MD, Malika Benkerrou, MD, Isabelle Thuret, MD

Blood (2019) 134 (Supplement_1): 1001.

https://doi.org/10.1182/blood-2019-127221

Published: 2019

Journal Articles

The First Case Report of Tazobactam Induced Thrombocytopenia

Minh-Tri H. Nguyen, MD, Pavneet Kaur, MD, Richard H. Aster, MD, Vidya Krishnan, MD MHS

Blood (2019) 134 (Supplement_1): 4897.

https://doi.org/10.1182/blood-2019-126227

Published: 2019

Journal Articles

Prophylactic Antibiotic Use and Risk of Meningococcal Infections in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Treated with Eculizumab Who Received Meningococcal Vaccination: Results from the International PNH Registry

Christopher J. Patriquin, MDFRCPC,MSc, Austin Kulasekararaj, MDMBBS,MRCP,FRCPath, Régis Peffault de Latour, MD PhD, Jun-Ho Jang, MD PhD, Saskia Langemeijer, MD PhD, Alexey A. Maschan, MD, Amanda Wilson, PhD, Deepak Jain, Jaroslaw P. Maciejewski, MD PhD

Blood (2019) 134 (Supplement_1): 4802.

https://doi.org/10.1182/blood-2019-127005

Published: 2019

Journal Articles

Cross-Reactivity of Drug-Dependent Antibodies in Patients with Immune Thrombocytopenia Induced By Beta-Lactam Antibiotics

Matthew John Slaught, BS, Daniel W. Bougie, PhD, Richard H. Aster, MD

Blood (2019) 134 (Supplement_1): 2350.

https://doi.org/10.1182/blood-2019-131375

Published: 2019

Journal Articles

Investigating Antibiotic Exposure and Risk of Severe Acute Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Razan Mohty, MD, Remy Dulery, MD, Giorgia Battipaglia, MD, Eolia Brissot, MD PhD, Clemence Mediavilla, MD, Simona Sestili, MD, Tounes Ledraa, MD, Béatrice Gaugler, PhD, Agnès Bonnin, Mohamad Mohty, MD PhD, Florent Malard, MD PhD

Blood (2019) 134 (Supplement_1): 4539.

https://doi.org/10.1182/blood-2019-125213

Published: 2019

Journal Articles

Thrombin: A Driver or Attenuator of Bone Disease on Hemophilia?

Galen Goldscheitter, BS, BA, Robert Klein, MD, Jason A Taylor, MD PhD

Blood (2019) 134 (Supplement_1): 4916.

https://doi.org/10.1182/blood-2019-130698

Published: 2019

Journal Articles

Serologic Characterization of Antibodies in Patients Experiencing Piperacillin-Induced Immune Thrombocytopenia

Mark Rasmussen, Daniel W. Bougie, PhD, Gregory H. Denomme, Richard H. Aster, MD

Blood (2019) 134 (Supplement_1): 1078.

https://doi.org/10.1182/blood-2019-130966

Published: 2019

Journal Articles

Pharmacotherapy Interventions and Barriers to Treatment of Sickle Cell Disease in Ibadan, Nigeria

Ijele Adimora, Titilola S. Akingbola, MBBS, FWACP, Frederick Lansigan, MD, Jack van Hoff, MD

Blood (2018) 132 (Supplement 1): 3523.

https://doi.org/10.1182/blood-2018-99-118384

Published: 2018

Journal Articles

Role of Point-of-Care Device in Improving Sickle Cell Newborn Screening Feasibility in Haiti

Ofelia A. Alvarez, MD, Tally Hustace, ARNP, Mimose Voltaire, RN, Rodrigueson Rizil, Ulrick Liberus, Rony Saint Fleur, MD

Blood (2018) 132 (Supplement 1): 3670.

https://doi.org/10.1182/blood-2018-99-115384

Published: 2018

Journal Articles

CD34+ Derived Microparticles Regulate Apoptosis in Normal and Acute Myeloid Leukemia Cells

Angeliki Xagorari, PhD, Sarantis Tsetsakos, Bsc, Zoi Katana, Konstantinos Krikonis, undergraduate student, Anastasia Kouvatsi, Katerina Chlichlia, Assistant Professor, Achilles Anagnostopoulos, Damianos Sotiropoulos, MD

Blood (2018) 132 (Supplement 1): 5090.

https://doi.org/10.1182/blood-2018-99-114425

Published: 2018

Journal Articles

Understanding Health Knowledge Gaps to Optimize Transitions of Care for Young Adults with Sickle Cell Disease

Cecelia Calhoun, MD MPHS, Lingzi Luo, MSW, MPH, Ana Baumann, PhD, Aimee James, PhD, Allison King, MD MPH, PhD

Blood (2018) 132 (Supplement 1): 2274.

https://doi.org/10.1182/blood-2018-99-113150

Published: 2018

Journal Articles

Metabolism of Acute Myeloid Leukemia Cell Lines Alters with Passage in 2D Culture and Remains Stable in 3D

Sophia Zemenides, BSc, MBBS, MRCP, MSc, Joana Dos Santos, MSc, Louise Enfield, Athanasios Mantalaris, PhD, Nicki Panoskaltsis, MD PhD FRCP

Blood (2018) 132 (Supplement 1): 2787.

https://doi.org/10.1182/blood-2018-99-118648

Published: 2018

Journal Articles

No Demonstrable Benefit of Penicillin in a Vaccinated Population of Children with Sickle Cell Disorder

Louise Smith, RCN MSc, Elizabeth Ryan, MB ChB, Russell D Keenan, MBChB, PhD FRCP, FRCPath, Rekha Thangavelu, MB ChB FRCP FRCPath

Blood (2018) 132 (Supplement 1): 4927.

https://doi.org/10.1182/blood-2018-99-119768

Published: 2018

Journal Articles

Optimization of Dose Regimen for ALXN1210, a Novel Complement C5 Inhibitor, in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results of 2 Phase 1/2 Studies

Alexander Roeth, MD, Scott T. Rottinghaus, MD, Anita Hill, MBChB (Hons), PhD, Jin Seok Kim, MD PhD, Hubert Schrezenmeier, MD, Louis Terriou, MD, Alvaro Urbano-Ispizua, MD, Richard A. Wells, MD DPhil, Jun Ho Jang, MD PhD, Jeff Szer, MB, BS, FRACP, Rasha Aguzzi, MS, Eric Scott Bachman, MD PhD, Andrew I. Damokosh, PhD, Lori Shafner, PhD, Jong-Wook Lee, MD

Blood (2017) 130 (Supplement 1): 3482.

https://doi.org/10.1182/blood.V130.Suppl_1.3482.3482

Published: 2017

Journal Articles

Stopping Folic Acid Supplementation in Hydroxyurea Treated Children with Sickle Cell Disease

Louise Smith, RCN MSc, Amy Littler, RCN, Kate LE Phillips, PhD, Russell D Keenan, MBChB, PhD FRCP, FRCPath

Blood (2017) 130 (Supplement 1): 3546.

https://doi.org/10.1182/blood.V130.Suppl_1.3546.3546

Published: 2017

Journal Articles

Improving the Diagnosis and Early Follow-up of Children with Sickle Cell Disease Born in Mirebalais Haiti

Rose Mintor, Steve Morisseau, Romain Jean Louis, Marlene Damas Borgella, Christophe Milien, Marc Julmisse, Joseph Ubaike, Chris Wong, Michelle Niescierenko, Natasha Archer, MD

Blood (2017) 130 (Supplement 1): 3353.

https://doi.org/10.1182/blood.V130.Suppl_1.3353.3353

Published: 2017

Journal Articles

Optimization of Ex Vivo Activation and Expansion of T Cells for Therapy of Lymphoma Via Antagonism of PI3K δ and Vasoactive Intestinal Peptide Signaling

Edmund K. Waller, MD, Mojitabe Hassan, BS, Anna B. Morris, Jasmin Jeffery, Kunhee Lee, Neera Jagirdar, MD, Ashley D. Staton, MD, Christopher Flowers, MD, Cynthia Gaylor, RN, Todd A. Sulchek, PhD, Christopher Thomas Petersen, BS

Blood (2017) 130 (Supplement 1): 3195.

https://doi.org/10.1182/blood.V130.Suppl_1.3195.3195

Published: 2017

Journal Articles

Large-Scale, Bioreactor-Generated Expansion of Umbilical Cord Blood Tissue-Derived Mesenchymal Stromal Cells for Clinical Use

Blood (2017) 130 (Supplement 1): 3198.

https://doi.org/10.1182/blood.V130.Suppl_1.3198.3198

Published: 2017

Journal Articles

Lack of an Alberta Newborn Screening Program Is Associated with Delayed Diagnosis of Sickle Cell Disease

Dania Monagel, MDFRCPC,FAAP, Michael Leaker, MDFRCPC, Doan Le, MDFRCPC,FAAP, Nicola A. Wright, MSc, MD FRCPC, Angela Ruzycki, MacGregor Steele, MD FRCPC

Blood (2017) 130 (Supplement 1): 2255.

https://doi.org/10.1182/blood.V130.Suppl_1.2255.2255

Published: 2017

Journal Articles

Quality of Care in United States Children with Sickle Cell Anemia

Julie Kanter, MD, Carlton Dampier, MD, Irene Agodoa, MD, Robin Howard, Sally Wade, Virginia Noxon, PhD, Samir K. Ballas, MD

Blood (2017) 130 (Supplement 1): 2098.

https://doi.org/10.1182/blood.V130.Suppl_1.2098.2098

Published: 2017

NARROW

Evaluation of Outcomes and Quality of Care in Children with Sickle Cell Disease Diagnosed By Newborn Screening: A Real-World Nation-Wide Study in France

The First Case Report of Tazobactam Induced Thrombocytopenia

Prophylactic Antibiotic Use and Risk of Meningococcal Infections in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Treated with Eculizumab Who Received Meningococcal Vaccination: Results from the International PNH Registry

Cross-Reactivity of Drug-Dependent Antibodies in Patients with Immune Thrombocytopenia Induced By Beta-Lactam Antibiotics

Investigating Antibiotic Exposure and Risk of Severe Acute Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Thrombin: A Driver or Attenuator of Bone Disease on Hemophilia?

Serologic Characterization of Antibodies in Patients Experiencing Piperacillin-Induced Immune Thrombocytopenia

Pharmacotherapy Interventions and Barriers to Treatment of Sickle Cell Disease in Ibadan, Nigeria

Role of Point-of-Care Device in Improving Sickle Cell Newborn Screening Feasibility in Haiti

CD34+ Derived Microparticles Regulate Apoptosis in Normal and Acute Myeloid Leukemia Cells

Understanding Health Knowledge Gaps to Optimize Transitions of Care for Young Adults with Sickle Cell Disease

Metabolism of Acute Myeloid Leukemia Cell Lines Alters with Passage in 2D Culture and Remains Stable in 3D

No Demonstrable Benefit of Penicillin in a Vaccinated Population of Children with Sickle Cell Disorder

Optimization of Dose Regimen for ALXN1210, a Novel Complement C5 Inhibitor, in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results of 2 Phase 1/2 Studies

Stopping Folic Acid Supplementation in Hydroxyurea Treated Children with Sickle Cell Disease

Improving the Diagnosis and Early Follow-up of Children with Sickle Cell Disease Born in Mirebalais Haiti

Optimization of Ex Vivo Activation and Expansion of T Cells for Therapy of Lymphoma Via Antagonism of PI3K δ and Vasoactive Intestinal Peptide Signaling

Large-Scale, Bioreactor-Generated Expansion of Umbilical Cord Blood Tissue-Derived Mesenchymal Stromal Cells for Clinical Use

Lack of an Alberta Newborn Screening Program Is Associated with Delayed Diagnosis of Sickle Cell Disease

Quality of Care in United States Children with Sickle Cell Anemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only